[Skip to Content]
[Skip to Content Landing]
Views 288
Citations 0
Comment & Response
September 11, 2018

Antiplatelet Therapy After Coronary Artery Bypass Grafting

Author Affiliations
  • 1Division of Cardiology, University of Tennessee School of Medicine, Memphis
JAMA. 2018;320(10):1035. doi:10.1001/jama.2018.10442

To the Editor Dr Zhao and colleagues concluded that among patients undergoing elective coronary artery bypass graft (CABG) surgery with saphenous vein grafting, ticagrelor plus aspirin significantly increased graft patency after 1 year vs aspirin alone.1 However, based on current best evidence and standards of care, the aspirin dosage (100 mg/d) used in this study for the aspirin-alone group may have been suboptimal.2